CTLA4 and melanoma: The expression of immune-related genes also correlates with prognosis and response to melanoma immunotherapy as demonstrated after analysis of 45 patients submitted to anti-CTLA-4 therapy that had tumors with increased expression of genes related to immune signature (Ji et al., 2012).